Medical disclaimer: This article is general information, not medical advice. Semaglutide is a prescription medication, and decisions about it should be made with a qualified healthcare provider who knows your medical history.
Semaglutide has become one of the most talked-about treatments for weight loss. Originally developed to manage type 2 diabetes, it has shown strong results for weight reduction and is now widely used for that purpose under medical supervision. This article explains how semaglutide works, what the evidence shows about its results and risks, and how people in New York City can access it. Because this is a prescription medication with real benefits and real risks, the goal here is a balanced, accurate picture, not a sales pitch.
What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that help control blood sugar and support weight management. It was first approved under the brand name Ozempic for type 2 diabetes. Because of its effect on weight, it is also approved for weight management under the brand name Wegovy. A related daily pill for diabetes, Rybelsus, also contains semaglutide, and in December 2025, the FDA approved an oral form of Wegovy for weight loss (more on that below).
How Semaglutide Works
Semaglutide mimics a natural hormone in the body that helps regulate appetite and insulin. It works through a few main effects:
- Appetite reduction: it acts on the brain’s appetite centers, which lowers hunger and calorie intake.
- Increased fullness: it slows stomach emptying and promotes a feeling of fullness, which reduces the tendency to overeat.
- Better blood sugar control: by helping regulate blood sugar, it supports overall metabolic health.
What the Evidence Shows About Results
Semaglutide has produced significant weight loss in clinical trials, though the exact figures depend on the form and the trial:
- Injectable Wegovy (weekly semaglutide 2.4 mg) produced roughly 15% average body-weight loss in clinical trials, far more than placebo (STEP trials; FDA data).
- Oral Wegovy (the new daily 25 mg tablet) produced about 16.6% mean weight loss over 64 weeks with full adherence in the OASIS 4 trial, compared with about 2.7% for placebo, with roughly a third of adherent participants losing 20% or more (OASIS 4; Applied Clinical Trials, 2026).
Beyond weight, semaglutide has shown broader health benefits. In the large SELECT trial of adults with cardiovascular disease and overweight or obesity (without diabetes), it reduced major adverse cardiovascular events by about 20%, with weight loss sustained over roughly four years (NEJM SELECT trial). It has also been associated with improvements in blood pressure, cholesterol, and waist circumference.
One important caveat: research shows weight tends to return after stopping the medication. For that reason, semaglutide is generally used as a long-term treatment alongside lasting lifestyle changes, not a short course.
Side Effects and Safety (What You Should Know)
No honest discussion of semaglutide is complete without its risks, and this is a decision to make carefully with a doctor.
The most common side effects are gastrointestinal: nausea, vomiting, and diarrhea, which are often strongest when starting or increasing the dose and tend to ease over time (FDA prescribing information, 2025).
More importantly, semaglutide carries an FDA boxed warning, the agency’s most serious warning, regarding a risk of thyroid C-cell tumors seen in animal studies. Because of this, it is not recommended for people with a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other precautions your provider will consider include a history of pancreatitis, gallbladder disease, certain eye conditions, and pregnancy (FDA prescribing information).
This is exactly why semaglutide is prescription-only and requires medical supervision. A provider weighs these risks against the potential benefits for your specific situation.
How Semaglutide Compares to Alternatives
Semaglutide is not the only option. Its main alternative is tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes), which works on two hormone pathways rather than one. In a head-to-head trial called SURMOUNT-5, tirzepatide produced greater average weight loss than semaglutide over 72 weeks (NEJM, 2025). Which medication is appropriate depends on your health profile, tolerance, insurance, and your provider’s judgment.
How to Access Semaglutide in New York City
For New York City residents, getting semaglutide is straightforward but involves a few careful steps.
1. Consult a Healthcare Provider
Before starting semaglutide, it is essential to consult a provider who can assess whether the medication is appropriate for you. They will typically review your medical history to identify any conditions that would make it unsafe, evaluate your current health and other medications, and discuss your weight and health goals.
2. Get a Prescription
Semaglutide is available by prescription only. Your provider will prescribe it if they determine it is a suitable treatment for you.
3. Choose a Reputable Provider
Several clinics and healthcare facilities in New York City offer weight-management care. When choosing one, consider their experience and credentials in weight management, patient reviews, and whether they offer ongoing support and follow-up care. A responsible provider will monitor your progress and side effects over time, not simply hand over a prescription.
4. Cost and Insurance
Semaglutide can be expensive, and not all insurance plans cover it for weight loss. Check with your insurance provider to understand your coverage, and discuss costs and payment options with your clinic. Be cautious of sources offering semaglutide without a proper medical evaluation or at prices that seem too good to be true, as compounded or unregulated products have raised safety concerns.
Lifestyle Changes for the Best Results
Semaglutide works best alongside lasting lifestyle changes:
- A balanced diet rich in fruits, vegetables, lean proteins, and whole grains.
- Regular physical activity supports weight loss and overall fitness.
- Behavioral support, such as working with a nutritionist or counselor to address emotional eating and build healthy habits.
These changes not only improve results while on the medication, but they also matter for maintaining weight over the long term.
Final Thoughts
Semaglutide has become an important tool for weight management, with strong evidence behind its effects on weight and, in some patients, cardiovascular health. It also carries real risks and side effects, which is why it belongs in a plan guided by a qualified healthcare provider. For New York City residents, accessing it means consulting a provider, getting a prescription, and choosing a reputable clinic, and pairing the medication with healthy lifestyle changes gives the best chance of lasting results. As always, the right choice depends on your individual health, and that conversation should happen with your doctor.
Frequently Asked Questions
How much weight can you lose on semaglutide?
In clinical trials, injectable semaglutide (Wegovy) produced about 15% average body-weight loss, and the new oral Wegovy produced about 16.6% over 64 weeks with full adherence. Individual results vary, and weight loss is greatest when combined with diet and exercise (FDA; OASIS 4 trial, 2026).
What are the side effects of semaglutide?
The most common side effects are gastrointestinal: nausea, vomiting, and diarrhea, often strongest when starting. Semaglutide also carries an FDA boxed warning about a risk of thyroid C-cell tumors and is not recommended for people with certain thyroid cancer histories. Discuss risks with your provider (FDA prescribing information).
Is there a semaglutide pill for weight loss?
Yes. In December 2025, the FDA approved an oral form of Wegovy (a 25 mg daily tablet), the first GLP-1 pill for chronic weight management, with a US launch in early January 2026. Previously, semaglutide for weight loss was available only as a weekly injection.
Do you regain weight after stopping semaglutide?
Studies show weight tends to return after stopping the medication, which is why semaglutide is generally used as a long-term treatment alongside lasting lifestyle changes rather than a short course.
Is semaglutide or tirzepatide better for weight loss?
In a head-to-head trial (SURMOUNT-5), tirzepatide produced greater average weight loss than semaglutide. However, the best choice depends on your health profile, tolerance, insurance, and your provider’s judgment.
Sources
- US Food and Drug Administration and Novo Nordisk, Wegovy prescribing information and oral Wegovy approval (2025 to 2026)
- OASIS 4 phase 3 trial, oral semaglutide efficacy and safety (2025 to 2026)
- SELECT trial, New England Journal of Medicine, cardiovascular outcomes of semaglutide
- SURMOUNT-5 trial, New England Journal of Medicine, tirzepatide versus semaglutide
- Mayo Clinic and Cleveland Clinic, patient information on GLP-1 medications
